ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1358	National Cancer Institute	Html	en	Gastrointestinal Complications (PDQ®)–Health Professional Version	Expert-reviewed information summary about constipation, impaction, bowel obstruction, and diarrhea as complications of cancer or its treatment. The management of these problems is discussed.	complete bowel obstruction 0.653864 stool 0.625324 gastrointestinal tract 0.642496 Oncol Nurs Forum 0.609323 cancer-related diarrhea 0.733825 refractory diarrhea 0.683452 diarrhea management 0.729396 total bowel rest 0.605453 diarrhea events 0.682702 bone marrow transplantation 0.599048 PUBMED Abstract 0.628255 octreotide acetate 0.600127 bowel lumen 0.596911 abdominal pain 0.618725 progressive bowel obstruction 0.651874 normal bowel function 0.623449 bowel obstruction 0.807553 Support Care Cancer 0.590223 acute diarrhea 0.731833 traveler’s diarrhea 0.692746 regimen-related diarrhea 0.681582 small bowel 0.642547 somatostatin analog octreotide 0.636325 depot octreotide 0.600959	chemotherapy-induced diarrhea 0.813859 malignant bowel obstruction 0.739577 cancer care 0.622581 cancer treatment-induced diarrhea 0.733195 severe diarrhea 0.723383 irritable bowel syndrome 0.602845 patients 0.752157 Clin Oncol 0.637052 cancer patients 0.616135 radiation-induced diarrhea 0.788656 neurogenic bowel dysfunction 0.61585 diarrhea 0.944656 inflammatory bowel disease 0.603068 bone marrow 0.600992 gastrostomy tube 0.601159 Nutr Clin Pract 0.61137 pelvic radiation-induced diarrhea 0.726181 octreotide 0.694845 extraluminal bowel lesions 0.625405 Delayed diarrhea 0.692341 fecal impaction 0.682249 et al. 0.624888 Subcutaneous octreotide 0.602593	CLICK HERE
1366	National Cancer Institute	Html	en	Pruritus (PDQ®)–Health Professional Version	Expert-reviewed information summary about pruritus (itching of the skin) as a complication of cancer or its treatment. Approaches to the management and treatment of pruritus are discussed.	pruritus 0.960641 second-generation antihistamines 0.585479 skin type 0.575303 atopic dermatitis 0.673145 skin surface 0.599366 worst pruritus 0.717892 atopic dermatitis population 0.574946 severe non-dermatological pruritus 0.718081 skin lipids 0.573883 Acad Dermatol Venereol 0.589376 primary dermatitis 0.600506 significant skin breakdown 0.59383 blood flow 0.584198 allergic skin reactions 0.594569 patients 0.575543 Dermatol Venereol Leprol 0.585578 placebo-controlled study 0.5912 radiation therapy 0.686843 Int J Dermatol 0.586614 Pain Symptom Manage 0.63754 healthy skin 0.593613 dry skin 0.639653 neuropathic pruritus 0.745005 et al. 0.592668	skin cleansing 0.573636 treatment 0.596222 skin reactions 0.599238 Oncol Nurs Forum 0.699339 skin dermatitis 0.603221 Opioid-induced Pruritus 0.704011 skin 0.704869 uraemic pruritus 0.705232 PUBMED Abstract 0.858232 Altered skin integrity 0.588103 Skin care 0.624412 Acta Derm Venereol 0.596823 pruritus relief 0.700635 itch 0.57584 allergic contact dermatitis 0.578553 skin hydration 0.574125 Clin Exp Dermatol 0.593566 skin change 0.583853 aggravates dry skin 0.598514 chronic idiopathic urticaria 0.638535 cholestatic pruritus 0.69774 Dermatol Ther 0.606265 intractable pruritus 0.703673 chronic pruritus 0.736276	CLICK HERE
1446	National Cancer Institute	Html	en	Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)–Patient Version	Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.	cancer treatment 0.700679 oral mucositis pain 0.483396 tissue 0.465551 chemotherapy 0.631313 blood cell count 0.467595 mouth problems 0.466009 PDQ Oral Complications 0.468892 oral health exam 0.469677 mouth sores 0.537291 infections 0.470414 teeth 0.49264 neck radiation therapy 0.476468 high-dose chemotherapy 0.598756 cancer information summary 0.466904 oral mucositis 0.510415 stem cell transplant 0.72121 oral complications 0.763758 patients 0.61166 cancer patients 0.469036 radiation therapy patients 0.468456 dry mouth 0.687045 neck cancers 0.467921 radiation therapy 0.972855 Chronic dry mouth 0.472069 problems 0.532519	regular oral care 0.496586 oral care 0.520388 peroxide mouth rinses 0.475847 PDQ cancer information 0.50364 head 0.475462 mucous membranes 0.503677 mouth moist 0.469166 patient 0.472618 taste changes 0.470678 National Cancer Institute 0.465975 summary 0.488366 common oral complications 0.486948 Wipe mouth 0.467118 pain 0.536314 white blood cell 0.514465 tooth decay 0.48102 mouth guards 0.465834 gum disease 0.504216 salivary glands 0.547761 Managing Oral Complications 0.485092 PDQ summary 0.468583 mouth 0.82735 Different oral complications 0.468019 milder oral complications 0.467906	CLICK HERE
1604	National Cancer Institute	Html	en	Bladder and Other Urothelial Cancers Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for bladder cancer.	red blood cells 0.494369 cancer treatment 0.489394 bladder cancers 0.541229 urine 0.494083 ongoing clinical trials 0.492966 bladder urothelium 0.575205 following PDQ summaries 0.556519 Transitional cell carcinoma 0.483769 PDQ cancer information 0.750577 cancer increases 0.491939 false-negative test result 0.489029 bladder cancer 0.812624 clinical trials 0.684635 test result 0.523443 special test strip 0.489962 cancer information summary 0.626401 clinical trial 0.502183 breast cancer prevention 0.514992 false-positive test result 0.488801 cancer patients 0.484495 latest published information 0.497666 NCI’s PDQ 0.51339 cancer symptoms 0.50531 NCI PDQ cancer 0.589485	tests 0.518118 Squamous cell carcinoma 0.486084 PDQ Screening 0.538371 screening tests 0.491835 Cancer Information Service 0.53331 urothelial cancers 0.536876 PDQ Bladder 0.571685 Prevention Editorial Board 0.549647 treatment clinical trials 0.491831 National Cancer Institute 0.634201 PDQ documents 0.50321 cell carcinoma 0.486793 new treatment 0.498073 Cancer screening trials 0.570719 Cancer Care page 0.519283 PDQ database 0.508182 risk factor 0.512484 PDQ summary 0.54439 cells 0.496479 cancer information summaries 0.541898 comprehensive cancer information 0.541535 renal pelvis 0.488981 cancer 0.961972 Urothelial Cancers Screening 0.519534	CLICK HERE
1628	National Cancer Institute	Html	en	Urethral Cancer Treatment (PDQ®)–Patient Version	Urethral cancer occurs in men and women and can spread quickly to lymph nodes near the urethra. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for urethral cancer.	cancer treatment 0.362333 entire urethra 0.306444 lymph node dissection 0.557244 tissue 0.317299 body 0.398643 PDQ cancer information 0.410389 clinical trial search 0.378188 white blood cells 0.310278 bladder cancer 0.308764 clinical trials 0.773033 nearby lymph nodes 0.630197 cancer information summary 0.370147 clinical trial 0.499273 breast cancer prevention 0.294123 prostate gland 0.293841 patients 0.324988 invasive bladder cancer 0.301679 treatment clinical trial 0.300741 NCI PDQ cancer 0.319347 radiation therapy 0.651339 Urethral Cancer Treatment 0.356944 Treatment Editorial Board 0.30592 urethral cancer 0.837946 recurrent urethral cancer 0.334114	General information 0.298754 treatment 0.543719 new cancer treatments 0.306575 NCI-supported cancer 0.322826 cancer cells 0.450964 proximal urethral cancer 0.41852 urethral cancer spreads 0.344537 Cancer Information Service 0.306473 laser surgery 0.302658 patient 0.295185 treatment clinical trials 0.339398 anterior exenteration 0.294741 National Cancer Institute 0.373731 transurethral resection 0.314195 new treatment 0.34401 distal urethral cancer 0.388721 external radiation therapy 0.308401 cancer research process 0.298298 cancer clinical trials 0.402611 cancer information summaries 0.303961 comprehensive cancer information 0.304414 internal radiation therapy 0.302856 cancer 0.977674 standard treatment 0.307427	CLICK HERE
1674	National Cancer Institute	Html	en	Langerhans Cell Histiocytosis Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood Langerhans Cell Histiocytosis.	Recurrent LCH 0.49021 cancer treatment 0.458844 childhood LCH lesions 0.545029 body 0.479436 high-risk multisystem LCH 0.563365 PDQ cancer information 0.430462 clinical trial search 0.417075 steroid therapy 0.417152 LCH lesions 0.646087 refractory childhood LCH 0.507141 Refractory LCH 0.491285 clinical trials 0.840496 LCH cells 0.723911 skin-only LCH 0.533026 cancer information summary 0.406099 clinical trial 0.546139 Langerhans cell histiocytosis 0.451003 patients 0.432765 LCH 0.976752 diagnose LCH 0.533565 lymph nodes 0.422079 treatment 0.665224 Progressive LCH 0.491974 BRAF gene 0.403636 LCH multisystem disease 0.521252	recurrent childhood LCH 0.508123 cancer cells 0.427036 pituitary gland 0.410888 childhood lch 0.600077 Adult LCH sections 0.511455 multisystem lch 0.599051 LCH trials 0.499932 LCH treatment 0.529717 treatment clinical trials 0.417639 National Cancer Institute 0.432317 effects cancer treatment 0.398781 small LCH lesions 0.540477 new treatment 0.409482 LCH bone lesions 0.547532 Adult LCH 0.522754 body systems 0.391142 LCH CNS 0.492291 bone marrow 0.4649 cancer clinical trials 0.44841 single-system lch 0.515862 progressive childhood LCH 0.507794 childhood LCH skin 0.522098 cancer 0.650545 information 0.432489	CLICK HERE
1859	National Cancer Institute	Html	es	Tratamiento del cáncer de hipofaringe (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de hipofaringe.	Neck Cancer Cooperative 0.13741 pharyngeal cancers 0.150792 Pfister DG 0.13468 pyriform sinus treated 0.135606 Cancer Res 0.206838 Radiat Oncol Biol 0.237454 DeVita VT Jr 0.131516 pyriform sinus 0.18629 Natl Cancer Inst 0.207961 radiation therapy 0.254373 Head Neck Surg 0.418544 carcinoma treated with 0.123784 squamous carcinoma 0.207808 with surgery 0.155955 Mendenhall WM 0.309662 Head Neck 0.426668 estadio iv 0.131056 neck squamous 0.149286 Parsons JT 0.126343 radioterapia preoperatoria versus 0.132896 sinus treated with 0.147408 treated with surgery 0.145993 radioterapia posoperatoria 0.168742 Oral Oncol 0.128712 Hendrickson FR 0.131539	treatment based 0.121981 Otolaryngol Head Neck 0.206433 hypopharyngeal carcinomas 0.157978 radiotherapy with 0.12894 with poor prognosis 0.124956 hypopharyngeal squamous 0.152628 Spindle cell carcinoma 0.12283 Clin Oncol 0.138573 combined with neck 0.126143 Oncol Biol Phys 0.243047 combining radiotherapy with 0.126277 estadio iii 0.184936 radiotherapy with surgery 0.128843 Treat Options Oncol 0.123145 radioterapia adyuvante posoperatoria 0.177283 European Organization 0.12179 neck cancer 0.973991 undifferentiated carcinomas 0.126856 quimioterapia neoadyuvante 0.630349 locally advanced 0.131399 Hansen O 0.125257 induction chemotherapy 0.134893 neck carcinoma 0.172184 squamous cell carcinoma 0.867141	CLICK HERE
1887	National Cancer Institute	Html	es	Tratamiento del carcinoma de células de Merkel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del carcinoma de células de Merkel.	Cutan Pathol 0.403221 skin cancer 0.402076 critical review with 0.401107 cell carcinoma showing 0.404318 review with guidelines 0.401112 Australian Merkel cell 0.404544 Distinct merkel cell 0.404503 Am Acad Dermatol 0.404485 cell polyomavirus dna 0.402185 Curr Opin Oncol 0.401201 Cell Carcinoma Information 0.404476 7th ed 0.401399 Rockville Merkel Cell 0.404613 ganglios linfáticos centinela 0.405335 SEER Program 0.402412 cell carcinoma tumors 0.407605 Coit DG 0.402335 into merkel cell 0.405013 Seattle Cancer Care 0.401199 Cancer Care Alliance 0.401228 Natl Cancer Inst 0.40149 Merkel tumours 0.402858 patients with merkel 0.422467 with cutaneous merkel-cell 0.401294 Arch Dermatol 0.401934	cutaneous merkel-cell carcinoma 0.404932 with merkel cell 0.435163 Invest Dermatol 0.401806 neuroendocrine-merkel cell carcinoma 0.404323 Cancer Staging Manual 0.402011 patients from 0.401403 Surg Oncol 0.411261 Nghiem P 0.404669 New York 0.401702 merkel cell carcinoma 0.998942 specimens from patients 0.401221 Clin Oncol 0.41408 Dermatol Surg 0.40166 CCM recién 0.401912 Carcinoma Group 0.402481 cell carcinoma demographics 0.418051 primary merkel 0.405524 Trabecular carcinoma 0.402756 American Joint Committee 0.401365 merkel cell polyomavirus 0.432273 cell carcinoma after 0.40431 cell polyomavirus infection 0.402124 merkel-cell carcinoma 0.40673 from patients with 0.402629	CLICK HERE
2042	National Cancer Institute	Html	es	Exámenes de detección del cáncer de vejiga y otros cánceres uroteliales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las pruebas que se usan para detectar sistemáticamente el cáncer de vejiga.	Cancer Inst Monogr 0.315885 Cancer Institute Surveillance 0.316979 urine cytology 0.306951 cuadro clínico 0.318123 Cancer Statistics Review 0.328453 transitional cell carcinoma 0.316775 Cancer registry problems 0.313029 Sin embargo 0.315264 American Cancer Society 0.340114 Hunt VB 0.306661 case-control study 0.305353 bladder cancer 0.978775 Young TB 0.311698 Bladder histological changes 0.316494 undergoing hematuria 0.308248 Malignant bladder tumors 0.31586 Can hematuria 0.308153 risk factors 0.306901 personas negras 0.307528 PDQ Exámenes 0.306867 patients with hematuria 0.310947 Messing EM 0.31983 Estados Unidos 0.311295 Natl Cancer Inst 0.403227 second cancers 0.320702	screening study using 0.305437 Bladder Cancer Group 0.328941 patients with 0.328907 neuropathic bladder 0.315447 SEER Cancer Statistics 0.328432 urinary tract 0.322774 Urol Clin North 0.310774 estadio t2+ 0.30573 detección casero 0.305242 Occup Med 0.308003 Cancer Facts 0.314556 bladder followed 0.315821 Noone AM 0.305423 National Cancer Institute 0.366947 Soloway MS 0.307825 Epidemiol Biomarkers Prev 0.327488 cell carcinoma 0.322375 asymptomatic microhematuria 0.311534 Clin North Am 0.316485 cell cytology screening 0.305294 bladder tumor 0.350128 invasive bladder 0.335021 bladder toxicity from 0.31599 transitional cell 0.318191	CLICK HERE
3433	National Cancer Institute	Html	es	Plantas crucíferas y la prevención del cáncer	Hoja informativa que resume los resultados de estudios sobre las plantas crucíferas y el cáncer. Incluye una lista de plantas crucíferas y las guías alimenticias recomendadas para el consumo de verduras.	lung-cancer risk 0.307792 vegetable consumption 0.312833 Mehta RG 0.302691 risk only 0.307938 Breast Cancer Detection 0.318522 Crowley-Nowick P 0.30257 P1 polymorphisms 0.302724 from case-control studies 0.304583 Appleby P 0.302596 vitaminas c 0.302699 Estados Unidos 0.329183 American Journal 0.315502 enzima glutatión 0.302759 phytochemicals derived from 0.304521 PubMed Abstract 0.825953 Verhoeven DT 0.30258 Eggleston IM 0.302576 Drug Metabolism Reviews 0.304253 International Journal 0.303618 investigation into cancer 0.31721 cohort study 0.390686 Health Professionals 0.302655 S-transferase M1 0.306619 multiethnic case-control study 0.310202 plantas crucíferas 0.972584	Países Bajos 0.321735 mayores cantidades 0.306865 alto consumo 0.304048 Project follow-up cohort 0.305167 Multiethnic Cohort Study 0.310843 sustancias llamadas glucosinolatos 0.304891 among men 0.30319 Murillo G 0.302582 prospective cohort study 0.312078 lower lung 0.303353 fruit consumption 0.320125 Clinical Nutrition 0.310798 rectal cancer 0.307152 Ziegler RG 0.302564 breast cancer 0.357017 Goldbohm RA 0.316028 Cancer Institute 0.343115 género brassica 0.30299 prospective study 0.373394 Bajos—el Netherlands Cohort 0.307492 glutathione s-transferase 0.312115 vegetable intakes 0.305276 Netherlands Cohort Study 0.345768 glutathione s-transferase polymorphisms 0.30497	CLICK HERE